A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts Using retrospective data from ...

23andMe research cohort analysis finds higher risk of venous thromboembolism and pulmonary embolism for people with sickle cell trait, yet relatively low risk of blood clotting overall (WASHINGTON – ...

Investigators have provided precise estimates of excess venous thromboembolism (VTE) risk after major cancer surgery by cancer type. Using multiple Swedish nationwide registers such as the national ...

Blood clots represent a significant burden to the healthcare system. Venous thromboembolism (VTE) includes blood clots that form in the deep veins of the legs, as well as those in the lungs. A clot ...

Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major bleeding, in patients with provoked VTE and enduring risk factors, ...

Receipt of any RBC transfusion was significantly associated with increased risk for venous thromboembolism. The following article features coverage from the American Society of Nephrology’s Kidney ...

A pulmonary embolism occurs when part of a blood clot breaks off from a deep vein in the body, travels up to an artery or vein in your lungs, and causes a blockage. It is a type of venous ...

Diagnosis for deep vein thrombosis (DVT) typically involves imaging tests. Following diagnosis, a doctor can advise on suitable treatments. DVT occurs when blood clots form in deep veins. If these ...

The increased risk is likely due to the underlying cancer disease and adjuvant treatments, researchers find. Patients who underwent major surgery for 8 cancer types experienced an increased rate of ...